MedPath

A Female Specific Anterior Cruciate Ligament Menstrual Cycle Phased Rehab Programme

Not Applicable
Recruiting
Conditions
anterior cruciate ligament injury
Musculoskeletal - Other muscular and skeletal disorders
Injuries and Accidents - Other injuries and accidents
Physical Medicine / Rehabilitation - Physiotherapy
Registration Number
ACTRN12621000517875
Lead Sponsor
Auckland University of Technology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
72
Inclusion Criteria

Females 16 years old or older who have undergone anterior cruciate ligament surgery and have a regular menstrual cycle. Females who are using a copper IUD will be included. Females will also be included who use the progestin dosed IUD (the Mirena), however they must using the progestin dosed IUD for over one year.

Exclusion Criteria

Exclusion Criteria: Using the oral contraceptive pill , Allograft/synthetic graft, Cartilage damage > Grade II, Meniscal Repair, Revision surgery.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome will be limb symmetry index (%) of maximum quadriceps strength of injured versus uninjured leg as measured in kilograms by a one-repetition-maximum test on a leg extension machine. [First appointment of the twelve week programme (6 weeks post operatively)<br>Final appointment of the twelve week programme (18 weeks post operatively)]
Secondary Outcome Measures
NameTimeMethod
Self-reported knee function assessed using the Knee Injury and Osteoarthritis Outcome Score questionnaire. and the International Knee Documentation Committee questionnaire. [First appointment of the twelve week programme (6 weeks post operatively)<br>Final appointment of the twelve week programme (18 weeks post operatively)];Self-efficacy assessed using the Knee Self Efficacy Scale. [First appointment of the twelve week programme (6 weeks post operatively)<br>Final appointment of the twelve week programme (18 weeks post operatively)]
© Copyright 2025. All Rights Reserved by MedPath